Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,470.00
(
-1.06%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
106.93
(
0.00%
)
Bitcoin
70,718.00
(
0.29%
)
News Focus
News Focus

Replies to post #15715 on Momenta Pharmaceuticals, Inc. (MNTA)

Replies to #15715 on Momenta Pharmaceuticals, Inc. (MNTA)
icon url

DewDiligence

08/05/16 11:16 AM

#15716 RE: Bickema #15715

Necuparanib R&D expense was $0.7M during 2Q16, according to MNTA's PR (#msg-124305312).